Healthcare - Biotechnology - NASDAQ - US
$ 2.27
-3.4 %
$ 128 M
Market Cap
-1.92
P/E
INCOME STATEMENT
0
REVENUE
-66.1 M
OPERATING INCOME
-34 M
NET INCOME
EFFICIENCY
Earnings Waterfall
Rani Therapeutics Holdings, Inc.
| Revenue | 0 |
| Cost Of Revenue | 822 K |
| Gross Profit | -822 K |
| Operating Expenses | 66.1 M |
| Operating Income | -66.1 M |
| Other Expenses | -32.1 M |
| Net Income | -34 M |
Income Statement
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | |
|---|---|---|---|---|---|
| REVENUE | |||||
| Revenue | 0 | 0 | 2.7 | 0.5 | 1.0 |
| GROSS PROFIT | |||||
| Cost Of Revenue | 0.8 | 1.3 | 0 | 0 | 0 |
| Gross Profit | (0.8) | (1.3) | 2.7 | 0.5 | 1.0 |
| OPERATING INCOME | |||||
| Operating Expenses | 66.1 | 63.5 | 54.3 | 17.0 | 28.0 |
| Selling, General and Administrative Expenses | 26.5 | 26.8 | 27.8 | 5.0 | 3.5 |
| Research and Development Expenses | 39.6 | 36.6 | 26.5 | 12.0 | 24.6 |
| Operating Income | (66.1) | (63.5) | (51.6) | (16.5) | (27.1) |
| PRE-TAX INCOME | |||||
| Interest Income Expense | 5.1 | 1.1 | 0.5 | 0.1 | 10 K |
| Total Other Income | (1.8) | 0.2 | (1.4) | (0.1) | 0.5 |
| Pre-Tax Income | (67.9) | (63.3) | (53.0) | (16.7) | (26.6) |
| NET INCOME | |||||
| Tax Provision | 0 | 70 K | 41 K | 35 K | 10 K |
| Net Income | (34.0) | (63.3) | (53.1) | (16.7) | (26.6) |
| EPS | 1.33 | 2.66 | 2.69 | 0.85 | 1.35 |